Precision BioSciences Inc.
DTIL | NASDAQ
$6.50
-$0.17 (-2.55%)
At close: Sep 21, 2026, 4:00 PM ET
$6.46
-$0.04 (-0.62%)
Pre-market:
Sep 22, 2026, 7:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 34.26M | 68.7M | 48.73M | 25.1M | 115.53M | 24.29M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 34.26M | 68.7M | 48.73M | 25.1M | 115.53M | 24.29M |
Operating Income | -52.15M | -26.16M | -43.74M | -62.31M | -39.38M | -109.83M |
Interest Income | 4.24M | 6.76M | 7.69M | 3.47M | 208K | 822K |
Pretax Income | -46.61M | 7.17M | -42.53M | -72.91M | -30.6M | -109.01M |
Net Income | -45.72M | 7.17M | -61.32M | -111.64M | -30.6M | -109.01M |
Selling & General & Admin | 32.24M | 35.3M | 39.09M | 41.28M | 39.67M | 36.05M |
Research & Development | 54.17M | 59.56M | 53.38M | 46.12M | 115.24M | 98.06M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 86.41M | 94.86M | 92.46M | 87.41M | 154.91M | 134.11M |
Interest Expense | 1.42M | 1.78M | 2.23M | 1.11M | 132K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 86.41M | 94.86M | 92.46M | 87.41M | 154.91M | 134.11M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 12.83M | 6.83M | 3.84M | 2.93M | 1.96M | 1.73M |
Shares Outstanding (Diluted) | 12.83M | 6.88M | 3.84M | 2.93M | 1.96M | 1.73M |
EPS (Basic) | -3.56 | 1.05 | -15.96 | -38.10 | -15.60 | -62.85 |
EPS (Diluted) | -3.56 | 1.04 | -15.96 | -38.10 | -15.60 | -62.85 |
EBITDA | -42.43M | 13.53M | -32.04M | -62.79M | -20.27M | -99.19M |
EBIT | -45.19M | 8.95M | -40.3M | -71.8M | -30.47M | -109.01M |
Depreciation & Amortization | 2.75M | 4.58M | 8.26M | 9M | 10.2M | 9.81M |
Add to Watchlist
Select watchlists to add or remove DTIL